Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Submitted by
admin
on November 21, 2011 - 9:44am
Source:
Bloomberg
News Tags:
Gilead
Pharmasset
hepatitis C
Headline:
Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Do Not Allow Advertisers to Use My Personal information
